Unknown

Dataset Information

0

Alloreactive Regulatory T Cells Allow the Generation of Mixed Chimerism and Transplant Tolerance.


ABSTRACT: The induction of donor-specific transplant tolerance is one of the main goals of modern immunology. Establishment of a mixed chimerism state in the transplant recipient has proven to be a suitable strategy for the induction of long-term allograft tolerance; however, current experimental recipient preconditioning protocols have many side effects, and are not feasible for use in future therapies. In order to improve the current mixed chimerism induction protocols, we developed a non-myeloablative bone-marrow transplant (NM-BMT) protocol using retinoic acid (RA)-induced alloantigen-specific Tregs, clinically available immunosuppressive drugs, and lower doses of irradiation. We demonstrate that RA-induced alloantigen-specific Tregs in addition to a NM-BMT protocol generates stable mixed chimerism and induces tolerance to allogeneic secondary skin allografts in mice. Therefore, the establishment of mixed chimerism through the use of donor-specific Tregs rather than non-specific immunosuppression could have a potential use in organ transplantation.

SUBMITTER: Ruiz P 

PROVIDER: S-EPMC4655502 | biostudies-literature | 2015

REPOSITORIES: biostudies-literature

altmetric image

Publications

Alloreactive Regulatory T Cells Allow the Generation of Mixed Chimerism and Transplant Tolerance.

Ruiz Paulina P   Maldonado Paula P   Hidalgo Yessia Y   Sauma Daniela D   Rosemblatt Mario M   Bono Maria Rosa MR  

Frontiers in immunology 20151123


The induction of donor-specific transplant tolerance is one of the main goals of modern immunology. Establishment of a mixed chimerism state in the transplant recipient has proven to be a suitable strategy for the induction of long-term allograft tolerance; however, current experimental recipient preconditioning protocols have many side effects, and are not feasible for use in future therapies. In order to improve the current mixed chimerism induction protocols, we developed a non-myeloablative  ...[more]

Similar Datasets

| S-EPMC5669809 | biostudies-literature
| S-EPMC4172387 | biostudies-literature
| S-EPMC5773708 | biostudies-literature
| S-EPMC5877958 | biostudies-literature
| S-EPMC7917336 | biostudies-literature
| S-EPMC4523231 | biostudies-literature
| S-EPMC4702259 | biostudies-literature
| S-EPMC6418492 | biostudies-literature
2024-07-05 | GSE263200 | GEO
| S-EPMC8410037 | biostudies-literature